Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Concurrent Session 2: Epigenetics and Targeting Transcription

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Concurrent Session 2: Epigenetics and Targeting Transcription
  •  
  • Permission not
    granted for presentation
  •  
  •  
Rational cancer & immune cell therapy combinations a functional genomics approach
Daniel Peeper
Netherlands Cancer Institute, Amsterdam, Netherlands
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 4:15 PM-6:00 PM
Concurrent Session 2: Epigenetics and Targeting Transcription
Discovery and development of HIF-2a inhibitors for the treatment of clear cell renal cell carcinoma
Eli Wallace
Peloton Therapeutics, Inc., Dallas, TX, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 4:15 PM-6:00 PM
Concurrent Session 2: Epigenetics and Targeting Transcription
  •  
  • Permission not
    granted for presentation
  •  
  •  
Targeting the opposing roles of IFN for cancer immunotherapy
Andy J. Minn
Abramson Family Cancer Research Institute, Philadelphia, PA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 27, 2019 4:15 PM-6:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3